Could “TrumpRx” be the prescription for lower drug prices?

President Trump announced a landmark deal with Pfizer to cut drug prices and sell them on TrumpRx, a new direct-to-consumer federal website that’s slated to launch next year.

Prescription drug prices in the US are roughly 2.78 times higher on average than in 33 other high-income countries, a 2024 report by the RAND Corporation found — but some savings on TrumpRx are expected to reach up to 85%.

Still, the new deal has left Americans with some burning questions: Who will benefit? How much less will they pay? And will other pharmaceutical companies soon join?

Here’s a look at what the Pfizer deal and TrumpRx mean for American wallets. 6

Will everyone get cheaper drugs under TrumpRx?

The short answer: Most people will no

See Full Page